CI Auspice Broad Commodity Fund (CCOM) Quote

.19 +’53% we love Bayer

Pump it .18s for a 40% gain

NVDL $54 those $51s and $52s nice 6% flip at premarket open Yellen and Powell
Pump the markets at play enjoy

Wake up $weet$$ fill em bid$$$ $lap my a$$

Pump it up

Good observation, Red.

The junkie$$ will fill em bid$$$ Let$$$$$ gooooooo$$$$$

shane s on larry pesavento 130pm

The flipper$$ will run out of ammo very quickly with massive per market pre$$ure coming $weet$$$

"But we would now like to do some more focused, faster path, tumor shrinkage endpoint trials. So we are, as we evaluate, I mean, we have so many opportunities in front of us now. Really, the challenge is choosing. Right? And so we we gotta steer ourselves, to the extent we can, towards that directio

If you think someone posting on this board is pumping/moving shares in any company, you’re delusional. The audience is so small, it can’t possibly have an impact one way or another. The only thing it can do is help someone that is following a company with their research.

I don’t und

"Super" Happy *BirthDay*, Capgain " .. !!

Trump on Gutfield last night was great.

its easy to see a communicator would make a much better President.

no notes, no teleprompter, no agenda, just down earth talking.

chill out, u might wake your boyfriend.

Rolled up the 30’$$$ $weet$$ $moking it like a joint$$$$$

FDA fa$t track on $tandby new$$$ $weet$$$

Ok

Thank you for your monthly BIEL post. I see you’re still banging the table!

#1 Life is 10% what happens to you and 90% how you react to it.
Charles R. Swindoll
#2 If you have the facts, bang on the facts, if you have opinion bang on opinion, if you

Pre-market pressure $weet$$$$ Grab all you can at the$e level$$ a gift from heaven above$$$$$

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

Who will take u$ to heaven $weet$$$
Bristol Myers Squibb

AstraZeneca

Merck

Novartis

Roche

AbbVie

Johnson & Johnson

Accord Healthcare

Amgen

Astellas Pharma